News And Announcements
Raven Property Groups swings to loss on weak rouble
Russia-focused commercial property investment outfit Raven Property Group on Monday reported that it swung to a full-year loss due to a weak rouble exchange rate.
Strategic Minerals to take 100pc stake in Cornwall Resources
Strategic Minerals has entered into arrangements with New Age Exploration to acquire its entire 50% shareholding in Cornwall Resources - the joint venture vehicle developing the Redmoor tin and tungsten project in Cornwall, it announced on Monday.
Omega Diagnostics CE-marks 'VISITECT CD4' test for HIV patients
Medical diagnostics company Omega Diagnostics announced on Monday that it has CE-marked its ‘VISITECT CD4’ advanced disease test for monitoring people living with HIV.
Microsaic expands in Asia with OEM deal
Mass spectrometry instrument developer Microsaic Systems has signed an original equipment manufacturer (OEM) agreement with Biometrics Technologies (BMT) for the integration of the ‘Microsaic 4500 MiD’ MS detector with BMT's ‘High Performance Liquid Chromatography’ (HPLC) equipment, for distribution in southeast Asia, Korea and India.
Smart Metering Systems to supply meters to SSE small business customers
Metering services company Smart Metering Systems (SMS) has signed an agreement with SSE Energy Supply, under to which SSE appointed SMS as its preferred national supplier to provide services as an integrated smart meter installer and meter asset provider to its small business customers.
Shore Capital gets FCA clearance for Stockdale Securities deal
The Financial Conduct Authority has approved stockbroker Shore Capital's acquisition of Stockdale Securities.
EasyJet pulls out of Alitalia consortium
EasyJet said on Monday that it has decided to withdraw from a consortium set up to consider bidding for bankrupt Alitalia.
Capital & Regional faces tough conditions but still a 'buy' for Berenberg
Berenberg has reduced its price target on Capital & Regional but insisted the property group remained a buying opportunity, despite the challenging conditions surrounding shopping centres.
Dermira shares rocket after positive drug trial
Shares in Nasdaq’s Dermira have more than doubled after the biopharmaceutical company unveiled positive trials for a possible new eczema treatment.
Morgan Stanley ups rating on Rolls Royce on improving cashflow
Morgan Stanley has upgraded its rating on engines group Rolls-Royce, arguing that market share gains are likely to drive sector-beating cashflow growth.
Sorrell's S4 Capital sees revenue leap after acquisitions
Sir Martin Sorrell's new advertising venture S4 Capital saw annual revenues leap after acquiring Mediamonks and MightyHive.
Commerzbank and Deutsche Bank confirm merger talks; shares jump
Shares in Deutsche Bank and its smaller rival Commerzbank rallied on Monday, after the two banks confirmed long-held speculation they were in merger talks.
Travelodge eyes major expansion after five-year turnaround
Travelodge hailed its turnaround on Monday, as annual revenues jumped, and unveiled plans to open another 100 hotels despite the current “uncertain” economic climate.
Cora Gold shares down despite positive test work data
West-Africa focussed exploration company Cora Gold was upbeat on the release of interim results from the preliminary metallurgical test work programme for oxide samples, taken from the zone A and Selin prospects at the Sanankoro Gold Discovery in the Yanfolila Gold Belt, Southern Mali on Monday.
ReNeuron Group begins dosing second cohort in hRPC study
Cell-based therapeutics company ReNeuron Group updated the market on progress with the ongoing phase 1 and 2 clinical trial in the US of its ‘hRPC’ cell therapy candidate in the blindness-causing disease, retinitis pigmentosa (RP).
Spectra Systems full-year profit to top market expectations
Spectra Systems, which provides secure transactions technology, said on Monday that profits for the year to the end of December 2019 will exceed market expectations.
PureTech Health's Karuna raises $68m in series B financing
Biopharmaceutical company PureTech Health announced on Monday that its affiliate Karuna Therapeutics has completed a $68m series B financing round, including the issuance of $5m in shares upon conversion of debt into equity.
Tlou Energy makes decent progress at Lesedi project
Botswana and southern Africa-focussed power delivery company Tlou Energy updated the market on the status of field operations at the Lesedi coal-bed methane project in Botswana on Monday, confirming it had drilled all six wells which comprised the Lesedi 3 and Lesedi 4 development pods as part of its recent field drilling programme.
Chairman Richard Morgan steps down from Motif Bio board
Clinical-stage biopharmaceutical company Motif Bio announced on Monday that Richard Morgan had tendered his resignation as non-executive chairman, and was stepping down from the board of directors to focus on other business commitments, effective immediately.
Allergy Therapeutics shares plunge after disappointing clinical trial
Shares in biotechnology company Allergy Therapeutics were plunging on Monday morning, after it announced disappointing top-line results from the phase 3 clinical trial ‘B301’ of its new adjuvanted birch allergoid product.